NCCN Guidelines

Neuroendocrine and Adrenal Tumors

Guidelines

- Adrenal Gland Tumors

- Extrapulmonary Poorly Differentiated: Neuroendocrine Carcinoma/Large or Small Cell Carcinoma/Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm

- Multiple Endocrine Neoplasia, Type 1

- Multiple Endocrine Neoplasia, Type 2

- Neuroendocrine and Adrenal Tumors

- Neuroendocrine Neoplasms of Unknown Primary

- Neuroendocrine Tumors of the Gastrointestinal Tract (Well-Differentiated Grade 1/2), Lung, and Thymus

- Neuroendocrine Tumors of the Pancreas (Well-Differentiated Grade 1/2)

- Pheochromocytoma/Paraganglioma

- Well-Differentiated Grade 3 Neuroendocrine Tumors

NCCN Guidelines in Practice™

Earn CME/CE and MOC credits for using the NCCN Guidelines to research your patient care decisions and clinical questions by clicking here.

Evidence Blocks

Guidelines for Patients

International

Harmonized

3025 Chemical Road, Suite 100, Plymouth Meeting, PA 19462
Phone: 215-690-0300
Fax: 215-690-0280
Copyright © National Comprehensive Cancer Network, All Rights Reserved.

No portion of this Site or any NCCN Content may be copied, transferred, reproduced, modified, or otherwise used for any purpose without NCCN’s express written permission.
See Legal Notices Section for additional notices and terms governing your use of this Site.